Company News Archives - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Dermata Therapeutics has reported positive topline data from the Phase Ib clinical trial where its product candidate, DMT310, was assessed…

19 Oct 2021

Entasis reports positive data from Phase III Acinetobacter drug trial

Entasis Therapeutics has reported positive topline data from the international Phase III ATTACK clinical trial of sulbactam-durlobactam (SUL-DUR) drug in people with Acinetobacter baumannii-caused infections. The gram-negative, opportunistic human pathogen…